Online Decision Aid for Prostate Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests an online tool called "Talk to Nathan About Prostate Cancer Screening" to determine its effectiveness in helping men make informed decisions about prostate cancer screening. It compares this tool to other standard decision aids and educational materials to identify which most effectively boosts understanding and reduces uncertainty about screening. Men aged 55-69 with an upcoming health exam, internet access, and no current urinary symptoms may be suitable for this study. Participants will use one of the decision aids before visiting their doctor and will complete surveys to provide feedback. As an unphased study, this trial offers a unique opportunity to contribute to research that may enhance decision-making tools for prostate cancer screening.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using an online decision aid, so it's unlikely that your medications will be affected.
What prior data suggests that the "Talk to Nathan About Prostate Cancer Screening" decision aid is safe and effective?
This trial focuses on the "Talk to Nathan About Prostate Cancer Screening" tool, an online resource designed to help individuals make informed decisions about prostate cancer screening. Research has shown that tools like "Talk to Nathan" can improve understanding and reduce confusion about whether to get screened.
Participants face no risk because "Talk to Nathan" is purely educational. It involves no medication or medical procedures, so there are no known negative side effects. This tool is as safe as reading a pamphlet or watching a video.
In summary, "Talk to Nathan" provides a safe and helpful way to learn about prostate cancer screening.12345Why are researchers excited about this trial?
Researchers are excited about the "Talk to Nathan about Prostate Cancer Screening" decision aid because it offers a new, interactive way to help patients make informed decisions about prostate cancer screening. Unlike typical decision aids, which might just provide information, "Talk to Nathan" engages users in a more personalized dialogue, potentially leading to better understanding and more personalized decision-making. This approach could empower patients to be more active participants in their healthcare, tailoring decisions to their own values and preferences. Researchers hope this method will improve patient satisfaction and lead to more tailored and effective screening choices.
What evidence suggests that the "Talk to Nathan About Prostate Cancer Screening" decision aid is effective for prostate cancer screening?
Research shows that the "Talk to Nathan About Prostate Cancer Screening" tool, available to participants in this trial, can enhance understanding of prostate cancer screening. Studies have found that it clarifies screening options, reducing confusion and stress in decision-making. Designed for easy comprehension, the tool aids those who find medical information challenging. Previous evaluations suggest that using this tool makes patients feel more informed and confident about their screening decisions. It serves as an important resource for anyone seeking to make informed health choices.36789
Are You a Good Fit for This Trial?
This trial is for men considering prostate cancer screening. It's suitable for those who want to learn more about their options and are willing to use online tools or read standard educational materials. Participants should be able to visit a primary care clinic for follow-up and complete surveys.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants use 'Talk to Nathan About Prostate Cancer Screening', a standard decision aid, or standard education materials
Follow-up
Participants complete surveys and are monitored for changes in decisional conflict, autonomous decision-making, and prostate cancer knowledge
What Are the Treatments Tested in This Trial?
Interventions
- Talk to Nathan About Prostate Cancer Screening
Find a Clinic Near You
Who Is Running the Clinical Trial?
David Siegel
Lead Sponsor
ICF Macro, Inc.
Collaborator